Sanofi

SNY · NASDAQ · USD

$39.92−1.84%−$0.75

Close · October 2, 2026

At a glance

Revenue growth
+5.49%
2025 vs 2024
Net income growth
+40.52%
2025 vs 2024
Net margin
16.7%
2024: 12.6%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue12,30011,24412,20513,17010,73510,606—14,157—11,118—12,698
Cost of revenue2,8893,0563,6303,4122,9922,889—4,085—3,439—3,841
Gross profit9,4118,1888,5759,7587,7437,717—10,072—7,679—8,857
Selling, general and administrative2,4922,3272,8192,2912,3212,222—2,681—2,605—2,579
Research and development2,2331,7472,2911,8341,9091,808—1,852—1,719—1,663
Operating income2,5872,2491,7403,7841,7122,424—4,079—2,032—3,477
EBIT2,5872,2491,7403,7841,7122,424—4,079—2,032—3,477
EBITDA3,8262,7843,4904,1972,5333,172—4,909—2,862—4,233
Interest expense15313838.022762.0154—265—253—318
Pre-tax income8282,014-1,1553,5081,4672,200—3,581—1,310—3,101
Income tax451420-348680230481—737—164—563
Net income3431,614-8012,8023,9401,872—2,815—1,133—2,525
Net income to common shareholders3431,614-8012,8023,9401,872—2,815—1,133—2,525
Basic EPS0.291.34-0.662.303.241.52—2.25—0.91—2.01
Diluted EPS0.281.34-0.662.303.231.52—2.25—0.91—2.01
Average shares (basic)1,1971,2041,2131,2181,2171,234—1,253—1,249—1,253
Average shares (diluted)1,1971,2041,2131,2181,2171,234—1,253—1,249—1,253
Dividend per share——4.12—————————